Medical Devices United States Bio-Pharma Market Report 2017 | Page 2

Report Description
“United States Bio-Pharma Market Report 2017” Order This Report by calling
BigMarketResearch.com at [phone].
The pharmaceuticals market has immensely flourished over the past few years. This trend has
been witnessed mostly in the U.S. owing to technological advancement and better
infrastructure qualities in comparison to any other region. A recently added report by Big
Market Research on the pharmaceutical sector, titled, “United States Bio-Pharma Market
Report 2017” highlights such factors.
There have been various attempts by the manufacturers of the U.S. bio-pharma market to
ensure progress of the industry. Recently, AstraZeneca, an U.S. based firm has revealed its new
data on how they expand portfolio regarding cancer medicines. They revealed this information
at American Society of Clinical Oncology (ASCO) in 2017. The company claims that three new
oncology medicines would help to address the unfulfilled requirements of patients with
bladder cancer, lung, and ovarian. These have been given permission to be sold in the market
within three years after it put forward its proposal. The company is at midway to deliver on its
pledge to launch six latest therapeutic intervention for cancer by 2020.